You are here

Article Text

Article menu
Download PDFPDF
Therapeutics
Pergolide reduced involuntary periodic leg movements and improved sleep in the restless legs syndrome

https://doi.org/10.1136/ebm.5.1.21

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Source of funding: Lilly Deutschland GmbH. Drugs provided by Eli Lilly and Company.

    • For correspondence: Dr T C Wetter, Max Planck Institute of Psychiatry, Kraepelinstrasse 10, D-80804 Munich, Germany. FAX +49-89-30622-550.

    • ↵* See glossary.), double-blind, placebo-controlled crossover trial.